To coincide with the upcoming 50th anniversary of the Selma March (March 7–25, 1965), the Ad Council is leading an unprecedented group of historic brands to launch a new series of public service advertisements (PSAs) on behalf of their Love Has No Labels campaign. First announced in February, the digital–first campaign is designed to further understanding and acceptance of all communities regardless of race, religion, gender, sexual orientation, age and ability. The new television and online video PSAs encourage audiences to examine and challenge their own implicit bias.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7459751-ad-council-love-has-no-labels-psa/
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Until recently, a one-size-fits-all approach for firefighter respiratory protection might have been considered the norm. However, no two fire stations are alike, and each has differing needs, preferences and expectations of their protective equipment. This understanding served as the key driver behind the development of a new and innovative self-contained breathing apparatus (SCBA) platform – called the M1 SCBA – that was unveiled today at the 125th French Firefighters Congress by MSA Safety Incorporated (NYSE: MSA), a global leader in firefighter safety.
To view the multimedia release go to:
https://www.multivu.com/players/English/8404751-msa-m1-scba-firefighter-breathing-apparatus/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
For the third consecutive season, John Frieda® Hair Care worked with lead stylist Odile collaborated with Rodarte creators Laura and Kate Mulleavy to develop a look that complemented the designers’ Fall/Winter 2014 collection—lauded by some critics as the brand’s most successful presentation to date—which was a nod to the carefree hair of the their youth. Because the hair was styled in long, messy waves, Odile utilized John Frieda® Hair Care products that would keep hair healthy while also maintaining texture, understanding that the style could veer to damaged and scraggly without the right stylers. The result: ephemeral and nostalgic creating a beautiful glow.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65957-john-frieda-hair-care-rodarte-fall-winter-2014
One of the most difficult realizations for those with loved ones fighting a serious illness is understanding that treatment is no longer working. No one wants to admit that it has become a losing battle against a serious illness. Many people are hesitant to call hospice for a loved one because they see it as “giving up.” In reality, contacting hospice is a choice that can lead to fewer worries and more meaningful moments during a serious illness or near the end of life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
LUNGevity, the nation’s leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable. The new Lung Cancer Navigator mobile app provides lung cancer patients with access to the latest medical and treatment information related to their specific lung cancer diagnosis, and serves as a convenient hub for organizing customized care and support networks, asking questions, describing and tracking symptoms, and managing multiple medications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7865551-lungevity-lung-cancer-navigator-app/
Most foods that cause constipation are not natural and this is where most people have a hard time understanding the word "natural." If you eat processed foods you will cause constipation. If you eat natural foods, you will eliminate constipation.
Most people who live in our communities have little or no understanding of the important role that professional city, town, and county managers make in the quality of their lives. To address this issue, Life, Well Run, a national campaign to raise awareness of and appreciation for the role professional local government managers play in leading effective, efficient, and ethical local governments and the value they bring to building great communities has been launched by ICMA, the International City/County Management Association.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62783-icma-life-well-run
Sage, a leading provider of business management software and services to more than 6 million small and midsized businesses worldwide, today announced the inaugural Sage Listens RV Tour, a 50-day, nationwide tour where Sage executives will meet with more than 50 Sage customers and bring attention to the importance of shopping locally in order to support the economy. Additionally, the Sage Listens RV tour will give the company an opportunity to gain a better understanding of how to develop features and services to better support its customers. The tour will feature lively and engaging customer visits, parties and special events – all while promoting the “Shop Local” concept.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62140-sage-16-city-nationwide-sage-listens-rv-relay
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
